KaloCyte, Inc.
- Biotech or pharma, therapeutic R&D
KaloCyte is a preclinical biotech startup developing A LIFELINE WHEN BLOOD IS NOT AVAILABLE. ErythroMer is a dry, shelf-stable, bioengineered artificial red blood cell (RBC) substitute for pre-hospital treatment of hemorrhage when blood is not available. KaloCyte is presenting a poster at the 2025 BLUE KNIGHT Showcase on 6/15: 2025 BLUE KNIGHT™ Showcase.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}